Log in

NASDAQ:OBSVObseva News Headlines

$2.70
+0.02 (+0.75 %)
(As of 08/13/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.66
Now: $2.70
$2.85
50-Day Range
$2.54
MA: $3.48
$6.15
52-Week Range
$1.63
Now: $2.70
$10.35
Volume639,800 shs
Average Volume823,998 shs
Market Capitalization$131.13 million
P/E RatioN/A
Dividend YieldN/A
Beta0.79

Headlines

Obseva (NASDAQ OBSV) News Headlines

Source:
DateHeadline
Obseva (NASDAQ:OBSV) Downgraded by Zacks Investment ResearchObseva (NASDAQ:OBSV) Downgraded by Zacks Investment Research
marketbeat.com - August 13 at 5:33 AM
Obseva (NASDAQ:OBSV) Trading Down 8.5%Obseva (NASDAQ:OBSV) Trading Down 8.5%
americanbankingnews.com - August 11 at 8:38 PM
Obseva (NASDAQ:OBSV) Stock Price Up 10.2%Obseva (NASDAQ:OBSV) Stock Price Up 10.2%
americanbankingnews.com - August 10 at 8:06 PM
ObsEva SA to present at the Wedbush PacGrow Healthcare Virtual Conference, August 11 - 12, 2020ObsEva SA to present at the Wedbush PacGrow Healthcare Virtual Conference, August 11 - 12, 2020
marketwatch.com - August 9 at 9:01 AM
Obseva (NASDAQ:OBSV) Announces  Earnings ResultsObseva (NASDAQ:OBSV) Announces Earnings Results
americanbankingnews.com - August 8 at 5:50 PM
ObsEva SA to present at the Wedbush PacGrow Healthcare Virtual Conference, August 11 – 12, 2020 - Yahoo Finance UKObsEva SA to present at the Wedbush PacGrow Healthcare Virtual Conference, August 11 – 12, 2020 - Yahoo Finance UK
uk.finance.yahoo.com - August 7 at 4:46 AM
ObsEva Announces Second Quarter 2020 Financial Results and Business Update - GlobeNewswireObsEva Announces Second Quarter 2020 Financial Results and Business Update - GlobeNewswire
globenewswire.com - August 6 at 1:21 AM
ObsEva Announces Second Quarter 2020 Financial Results and Business UpdateObsEva Announces Second Quarter 2020 Financial Results and Business Update
finance.yahoo.com - August 6 at 1:21 AM
ObsEva SA: ObsEva SA to Hold Conference Call Monday, July 6 to Discuss Results from Phase 3 PRIMROSE 1 and PRIMROSE 2 TrialsObsEva SA: ObsEva SA to Hold Conference Call Monday, July 6 to Discuss Results from Phase 3 PRIMROSE 1 and PRIMROSE 2 Trials
www.bloomberg.com - August 1 at 7:19 PM
Obseva SA (NASDAQ:OBSV) Short Interest UpdateObseva SA (NASDAQ:OBSV) Short Interest Update
www.americanbankingnews.com - July 31 at 10:00 PM
Obseva SA (NASDAQ:OBSV) Receives Average Rating of "Buy" from BrokeragesObseva SA (NASDAQ:OBSV) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - July 30 at 2:25 AM
Obseva (NASDAQ:OBSV) Stock Price Down 5.5%Obseva (NASDAQ:OBSV) Stock Price Down 5.5%
www.americanbankingnews.com - July 20 at 8:38 PM
ObsEva SA Awarded Clinical Science Award for Oral Presentation at ESHRE Virtual 36th Annual Meeting, July 2020 - GlobeNewswireObsEva SA Awarded Clinical Science Award for Oral Presentation at ESHRE Virtual 36th Annual Meeting, July 2020 - GlobeNewswire
www.globenewswire.com - July 15 at 8:18 AM
ObsEva Phase 3 Data, And Other News: The Good, Bad And Ugly Of Biopharma - Seeking AlphaObsEva Phase 3 Data, And Other News: The Good, Bad And Ugly Of Biopharma - Seeking Alpha
seekingalpha.com - July 8 at 7:27 AM
ObsEvas linzagolix successful in late-stage uterine fibroid studyObsEva's linzagolix successful in late-stage uterine fibroid study
seekingalpha.com - July 7 at 3:39 PM
UPDATE: BMO Capital Downgrades ObsEva (OBSV) to Market Perform - StreetInsider.comUPDATE: BMO Capital Downgrades ObsEva (OBSV) to Market Perform - StreetInsider.com
www.streetinsider.com - July 7 at 5:38 AM
UPDATE: JPMorgan Downgrades ObsEva (OBSV) to Neutral - StreetInsider.comUPDATE: JPMorgan Downgrades ObsEva (OBSV) to Neutral - StreetInsider.com
www.streetinsider.com - July 7 at 5:38 AM
Pre-Market Movers In Healthcare Sector - OBSV, MGTA, ELGX... - NasdaqPre-Market Movers In Healthcare Sector - OBSV, MGTA, ELGX... - Nasdaq
www.nasdaq.com - July 6 at 12:39 PM
The Week Ahead In Biotech: Endo, Eagle Pharma FDA Decisions, ObsEva Late-Stage Readouts In Focus - BenzingaThe Week Ahead In Biotech: Endo, Eagle Pharma FDA Decisions, ObsEva Late-Stage Readouts In Focus - Benzinga
www.benzinga.com - July 6 at 12:39 PM
ObsEva down 42% on late-stage linzagolix data - Seeking AlphaObsEva down 42% on late-stage linzagolix data - Seeking Alpha
seekingalpha.com - July 6 at 12:39 PM
Form 6-K ObsEva SA For: Jul 06 - StreetInsider.comForm 6-K ObsEva SA For: Jul 06 - StreetInsider.com
www.streetinsider.com - July 6 at 7:39 AM
BRIEF-Obseva: Positive Results From Two Phase 3 Studies Of Yselty® (Linzagolix) - ReutersBRIEF-Obseva: Positive Results From Two Phase 3 Studies Of Yselty® (Linzagolix) - Reuters
www.reuters.com - July 6 at 2:39 AM
ObsEva Announces Positive Results from two Phase 3 Studies, PRIMROSE 1 and 2, of Yselty® (linzagolix) for the Treatment of Uterine Fibroids - GlobeNewswireObsEva Announces Positive Results from two Phase 3 Studies, PRIMROSE 1 and 2, of Yselty® (linzagolix) for the Treatment of Uterine Fibroids - GlobeNewswire
www.globenewswire.com - July 6 at 2:39 AM
ObsEva Announces Positive Results from two Phase 3 Studies, PRIMROSE 1 and 2, of Yselty® (linzagolix) for the Treatment of Uterine FibroidsObsEva Announces Positive Results from two Phase 3 Studies, PRIMROSE 1 and 2, of Yselty® (linzagolix) for the Treatment of Uterine Fibroids
finance.yahoo.com - July 6 at 2:39 AM
ObsEva SA to present at ESHRE Virtual 36th Annual Meeting, July 5-8, 2020 - GlobeNewswireObsEva SA to present at ESHRE Virtual 36th Annual Meeting, July 5-8, 2020 - GlobeNewswire
www.globenewswire.com - July 3 at 9:50 AM
ObsEva SA: ObsEva and Yuyuan BioScience Technology Announce Submission of the Pre-IND Dossier for Nolasiban with the Chinese NMPAObsEva SA: ObsEva and Yuyuan BioScience Technology Announce Submission of the Pre-IND Dossier for Nolasiban with the Chinese NMPA
www.finanznachrichten.de - July 2 at 6:14 PM
ObsEva and Yuyuan Bio submits pre-IND dossier for nolasiban in ChinaObsEva and Yuyuan Bio submits pre-IND dossier for nolasiban in China
seekingalpha.com - July 2 at 6:14 PM
Form 6-K ObsEva SA For: Jul 01 - StreetInsider.comForm 6-K ObsEva SA For: Jul 01 - StreetInsider.com
www.streetinsider.com - July 1 at 10:59 PM
Swiss stocks - Factors to watch on July 1 - ReutersSwiss stocks - Factors to watch on July 1 - Reuters
www.reuters.com - July 1 at 7:45 AM
BRIEF-Obseva And Yuyuan Bioscience Technology Submit Pre-Ind Dossier For Nolasiban With Chinese NMPA - ReutersBRIEF-Obseva And Yuyuan Bioscience Technology Submit Pre-Ind Dossier For Nolasiban With Chinese NMPA - Reuters
www.reuters.com - July 1 at 7:45 AM
ObsEva and Yuyuan BioScience Technology Announce Submission of the Pre-IND Dossier for Nolasiban with the Chinese NMPA - GlobeNewswireObsEva and Yuyuan BioScience Technology Announce Submission of the Pre-IND Dossier for Nolasiban with the Chinese NMPA - GlobeNewswire
www.globenewswire.com - July 1 at 7:45 AM
ObsEva SA to Hold Conference Call Monday, July 6 to Discuss Results from Phase 3 PRIMROSE 1 and PRIMROSE 2 Trials Evaluating Linzagolix in Women with Uterine Fibroids - GlobeNewswireObsEva SA to Hold Conference Call Monday, July 6 to Discuss Results from Phase 3 PRIMROSE 1 and PRIMROSE 2 Trials Evaluating Linzagolix in Women with Uterine Fibroids - GlobeNewswire
www.globenewswire.com - June 29 at 8:16 AM
ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2020 Annual General Meeting held on June 9, 2020 - GlobeNewswireObsEva SA Announces that Shareholders Approved all Board Proposals at its 2020 Annual General Meeting held on June 9, 2020 - GlobeNewswire
www.globenewswire.com - June 10 at 9:13 AM
ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2020 Annual General Meeting held on June 9, 2020 - Yahoo FinanceObsEva SA Announces that Shareholders Approved all Board Proposals at its 2020 Annual General Meeting held on June 9, 2020 - Yahoo Finance
finance.yahoo.com - June 9 at 7:26 PM
ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2020 Annual General Meeting held on June 9, 2020ObsEva SA Announces that Shareholders Approved all Board Proposals at its 2020 Annual General Meeting held on June 9, 2020
finance.yahoo.com - June 9 at 7:26 PM
BRIEF-Obseva Posts Data Showing Efficacy Of Linzagolix In Potential New Indication For Treatment Of Adenomyosis - ReutersBRIEF-Obseva Posts Data Showing Efficacy Of Linzagolix In Potential New Indication For Treatment Of Adenomyosis - Reuters
www.reuters.com - June 4 at 12:48 PM
Form 6-K ObsEva SA For: Jun 04 - StreetInsider.comForm 6-K ObsEva SA For: Jun 04 - StreetInsider.com
www.streetinsider.com - June 4 at 12:48 PM
ObsEva SA: ObsEva Announces Publication of Data Showing Efficacy of Linzagolix in a Potential New Indication for Treatment of AdenomyosisObsEva SA: ObsEva Announces Publication of Data Showing Efficacy of Linzagolix in a Potential New Indication for Treatment of Adenomyosis
www.finanznachrichten.de - June 4 at 7:47 AM
ObsEva Announces Publication of Data Showing Efficacy of Linzagolix in a Potential New Indication for Treatment of Adenomyosis - GlobeNewswireObsEva Announces Publication of Data Showing Efficacy of Linzagolix in a Potential New Indication for Treatment of Adenomyosis - GlobeNewswire
www.globenewswire.com - June 4 at 1:06 AM
ObsEva Announces Publication of Data Showing Efficacy of Linzagolix in a Potential New Indication for Treatment of AdenomyosisObsEva Announces Publication of Data Showing Efficacy of Linzagolix in a Potential New Indication for Treatment of Adenomyosis
finance.yahoo.com - June 4 at 1:06 AM
ObsEva SA to present at the Jefferies Virtual Healthcare Conference June 3rd, 2020 - GlobeNewswireObsEva SA to present at the Jefferies Virtual Healthcare Conference June 3rd, 2020 - GlobeNewswire
www.globenewswire.com - May 29 at 8:35 AM
ObsEva SA to present at the Jefferies Virtual Healthcare Conference June 3rd, 2020ObsEva SA to present at the Jefferies Virtual Healthcare Conference June 3rd, 2020
finance.yahoo.com - May 29 at 8:35 AM
BitSight Appoints Tim Adams to CFO, Jay Roxe to CMO - Yahoo FinanceBitSight Appoints Tim Adams to CFO, Jay Roxe to CMO - Yahoo Finance
finance.yahoo.com - May 26 at 2:06 PM
ObsEva Has A Promising Candidate For An Unmet NeedObsEva Has A Promising Candidate For An Unmet Need
seekingalpha.com - May 13 at 6:57 PM
ObsEva Has A Promising Candidate For An Unmet Need - Behind The Idea - Seeking AlphaObsEva Has A Promising Candidate For An Unmet Need - Behind The Idea - Seeking Alpha
seekingalpha.com - May 13 at 1:56 PM
New Forecasts: Heres What Analysts Think The Future Holds For ObsEva SA (NASDAQ:OBSV)New Forecasts: Here's What Analysts Think The Future Holds For ObsEva SA (NASDAQ:OBSV)
finance.yahoo.com - May 11 at 8:21 AM
New Forecasts: Here's What Analysts Think The Future Holds For ObsEva SA (NASDAQ:OBSV)New Forecasts: Here's What Analysts Think The Future Holds For ObsEva SA (NASDAQ:OBSV)
finance.yahoo.com - May 11 at 8:21 AM
Heres What Analysts Are Forecasting For ObsEva SA (NASDAQ:OBSV) After Its First-Quarter Results - Yahoo FinanceHere's What Analysts Are Forecasting For ObsEva SA (NASDAQ:OBSV) After Its First-Quarter Results - Yahoo Finance
finance.yahoo.com - May 8 at 5:13 PM
ObsEva Annual General Meeting 2020 Nasdaq:OBSV - GlobeNewswireObsEva Annual General Meeting 2020 Nasdaq:OBSV - GlobeNewswire
www.globenewswire.com - May 8 at 5:13 PM
Here's What Analysts Are Forecasting For ObsEva SA (NASDAQ:OBSV) After Its First-Quarter ResultsHere's What Analysts Are Forecasting For ObsEva SA (NASDAQ:OBSV) After Its First-Quarter Results
finance.yahoo.com - May 8 at 5:13 PM
ObsEva Annual General Meeting 2020ObsEva Annual General Meeting 2020
finance.yahoo.com - May 8 at 5:13 PM
This page was last updated on 8/14/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.